Probiotic - VSL#3

DIETARY_SUPPLEMENT2 trials

Sponsors

University of Alberta, University of California, San Diego

Conditions

Crohn's DiseaseInflammatory Bowel DiseaseObesity, Childhood

Phase 3

A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic Recurrence Following Surgery for Crohn's Disease.

CompletedNCT00175292

University of AlbertaCrohn's Disease, Inflammatory Bowel Disease

Start: 2003-12-31Target: 120Updated: 2008-05-14

Unknown Phase

Gut Microbiome, Adiposity, and Probiotics (GMAP)

CompletedNCT03533621

University of California, San DiegoObesity, Childhood

Start: 2014-09-04End: 2016-12-31Updated: 2018-05-23

Related Papers

The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease.

2014-11-06139 citations